Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes

• Fumitaka Haseda,

  Affiliation Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan

  ⨯
• Akihisa Imagawa,

  Affiliations Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan, Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita, Japan

  ⨯
• Hiroyoshi Nishikawa,

  Affiliations Experimental Immunology, Immunology Frontier Research Center, Osaka University, Suita, Japan, Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan

  ⨯
• Shinobu Mitsui,

  Affiliation Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan

  ⨯
• Chiharu Tsutsumi,

  Affiliation Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan

  ⨯
• Reiko Fujisawa,

  Affiliation Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan

  ⨯
• Hiroyuki Sano,

  Affiliation Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan

  ⨯
• Yuko Murase-Mishiba,

  Affiliation Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan

  ⨯
• Jungo Terasaki,

  Affiliation Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan

  ⨯
• Shimon Sakaguchi,

  Affiliation Experimental Immunology, Immunology Frontier Research Center, Osaka University, Suita, Japan

  ⨯
• Toshiaki Hanafusa

  * E-mail: hanafusa@osaka-med.ac.jp

  Affiliation Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan

  ⨯